News & Media

PRINCETON, N.J., April 21, 2023 /PRNewswire/ -- Oblato, Inc. (the Company), a subsidiary company of HLB Therapeutics in Korea,…

PRINCETON, N.J., Oct. 25, 2022 /PRNewswire/ -- Oblato, Inc. (the Company) a subsidiary company of HLB Therapeutics in Korea,…

PRINCETON, N.J., July 19, 2021 /PRNewswire/ -- Oblato, Inc. (the Company) announced today that it has received an agreement…

PRINCETON, N.J., March 3, 2021 /PRNewswire/ -- Oblato, Inc. (the Company), a wholly owned U.S. subsidiary of the Korean…

PRINCETON, N.J., Dec. 10, 2020 /PRNewswire/ -- Oblato, Inc. (the Company), a wholly owned U.S. subsidiary of the Korean…

The day before Thanksgiving in 2015, Mike Schuster’s life changed in an instant. Teresa and…

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse…